Summary
This prediction ended on 25.01.16 with a price of €106.10. With a performance of 5.94%, the SELL prediction by phonebroker for Bayer AG was trending in the wrong direction phonebroker has 50% into this predictionBayer is a multinational pharmaceutical and life sciences company headquartered in Germany. The company was founded in 1863 and has since grown to become a global leader in the fields of pharmaceuticals, agriculture, and consumer health. Bayer is listed on the Frankfurt Stock Exchange and also trades over-the-counter in the United States under the ticker symbol BAYZF. The company's products include prescription drugs, over-the-counter medicines, and agrochemicals, and it operates in more than 90 countries around the world.
Performance without dividends (%)
Name | 1w | 1m | 1y | 3y |
---|---|---|---|---|
Bayer AG | -5.146% | -5.146% | -45.120% | -41.720% |
iShares Core DAX® | 1.056% | 1.056% | 18.108% | 16.006% |
iShares Nasdaq 100 | -1.886% | -0.160% | 26.970% | 36.233% |
iShares Nikkei 225® | 2.553% | 4.359% | 17.676% | 10.955% |
iShares S&P 500 | -0.434% | 0.224% | 24.986% | 37.667% |
According to phonebroker what are the pros and cons of Bayer AG for the foreseeable future?
Pros
Cons
Comments by phonebroker for this prediction
In the thread Bayer AG diskutieren
phonebroker stimmt dem Sentiment von 'Buy' nicht zu
phonebroker stimmt am 20.01.2016 dem Buy-Gesamtsentiment mit dem Kursziel 130.73€ nicht zu.